Listed

Interface Inc: Form 10-Q for the period ended Apr 3, 2022

Filed with the SEC on May 10, 2022 and accepted by EDGAR at May 10, 2022, 16:09 ET.

Share

Management's discussion and analysis

As filed, 18,717 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our discussions below in this Item 2 are based upon the more detailed discussions about our business, operations and financial condition included in our Annual Report on Form 10-K for the fiscal year ended January 2, 2022, under Part II, Item 7 of that Form 10-K. Our discussions here focus on our results during the quarter ended April 3, 2022, or as of, April 3, 2022, and the comparable periods of 2021, and to the extent applicable, any material changes from the information discussed in that Form 10-K or other important intervening developments or information since that time. These discussions should be read in conjunction with that Form 10-K for more detailed and background information. The three-month periods ended April 3, 2022 and April 4, 2021 both include 13 weeks.

Forward-Looking Statements

This report contains statements which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include risks and uncertainties associated with the ongoing COVID-19 pandemic and the economic conditions in the commercial interiors industry as well as the risks and uncertainties discussed under the heading “Risk Factors” included in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended January 2, 2022, as supplemented in Part II, Item 1A of this report. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time.

Executive Overview

During the quarter ended April 3, 2022, we had consolidated net sales of $288.0 million, up 13.7% compared to $253.3 million in the first quarter last year, primarily due to the continued rebound in economic activity in certain countries following the impacts of COVID-19. Higher sales were primarily in the corporate office, education and healthcare market segments. Consolidated operating income was $27.4 million for the first quarter of 2022 compared to $16.9 million in the first quarter last year primarily due to higher sales in the current year period. Consolidated net income for the quarter ended April 3, 2022 was $13.3 million or $0.22 per share compared to $6.9 million or $0.12 per share in the first quarter last year.

Impact of the COVID-19 Pandemic

In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic, and the virus continues to impact areas where we operate and sell our products and services. The COVID-19 pandemic has had material adverse effects on our business, results of operations, and financial condition. The duration of the pandemic will ultimately determine the extent to which our operations are impacted.

During the first quarter of 2022, the COVID-19 pandemic continued to impact our global supply chain and manufacturing operations, which resulted in raw material shortages, raw material cost increases, higher freight costs, higher labor costs and shipping delays. These global supply chain and manufacturing challenges increased our costs and adversely affected our gross profit margin–particularly in our EAAA segment. New government imposed COVID-19 lockdowns in parts of China during the first quarter of 2022 adversely impacted sales in China by approximately 14% compared with the first quarter last year.

Analysis of Results of Operations

Consolidated Results

The following table presents, as a percentage of net sales, certain items included in our consolidated condensed statements of operations for the three-month periods ended April 3, 2022 and April 4, 2021:

Three Months Ended April 3, 2022 April 4, 2021
Net sales 100.0% 100.0%
Cost of sales 62.9 62.1
Gross profit on sales 37.1 37.9
Selling, general and administrative expenses 27.3 31.3
Restructuring and asset impairment charges 0.3 (0.1)
Operating income 9.5 6.7
Interest/Other expense, net 2.4 3.1
Income before income tax expense 7.1 3.6
Income tax expense 2.5 0.8
Net income 4.6% 2.8%

Consolidated Net Sales

Below is information regarding our consolidated net sales, and analysis of those results, for the three-month periods ended April 3, 2022, and April 4, 2021:

(in thousands)

Three Months Ended April 3, 2022 April 4, 2021 Percentage Change
Consolidated net sales $288,002 $253,260 13.7%

For the quarter ended April 3, 2022, consolidated net sales increased $34.7 million (13.7%) versus the comparable period in 2021, primarily due to higher sales volume and prices. Currency fluctuations had a negative impact on consolidated net sales of approximately $7.9 million (3.1%) for the first quarter of 2022, due primarily to the weakening of the Euro, Australian dollar and British Pound sterling against the U.S. dollar. On a market segment basis, the sales increase was primarily in the corporate office, education and healthcare market segments as a result of higher corporate reinvestment and government spending on school renovation projects.

Consolidated Cost and Expenses

The following table presents our consolidated cost of sales and selling, general and administrative expenses for the three-month periods ended April 3, 2022, and April 4, 2021:

(in thousands)

Three Months Ended April 3, 2022 April 4, 2021 Percentage Change
Cost of sales $181,203 $157,222 15.3%
Selling, general and administrative expenses 78,492 79,302 (1.0)%

For the quarter ended April 3, 2022, consolidated cost of sales increased $24.0 million (15.3%) compared to the first quarter of 2021, primarily due to higher sales and continuing inflationary pressures on raw materials, freight and labor costs. Currency translation had a positive impact on consolidated cost of sales in the first quarter of 2022 and partially reduced our costs by approximately $5.2 million (3.3%) compared to the same period last year. As a percentage of net sales, our cost of sales increased to 62.9% for the first quarter of 2022 versus 62.1% for the first quarter of 2021.

For the quarter ended April 3, 2022, consolidated selling, general and administrative (“SG&A”) expenses decreased $0.8 million (1.0%) versus the comparable period in 2021. Currency translation had a positive impact on consolidated SG&A expenses in the first quarter of 2022 and partially reduced our costs by approximately $1.9 million (2.7%) compared to the same period last year. SG&A expenses were also lower for the first quarter of 2022 due to lower severance costs and lower labor costs of approximately $2.6 million driven by employee headcount reduction initiatives in response to the impacts of COVID-19. These lower costs were partially offset by higher selling expenses of approximately $1.8 million during the first quarter of 2022 due to higher sales. As a percentage of sales, SG&A expenses decreased to 27.3% for the first quarter of 2022 versus 31.3% for the first quarter of 2021.

Restructuring Activities

On September 8, 2021, the Company committed to a new restructuring plan that continues to focus on efforts to improve efficiencies and decrease costs across its worldwide operations, involving the closure of the Company’s manufacturing facility in Thailand at the end of the first quarter of 2022. In the first quarter of 2022, we recognized restructuring charges of approximately $0.9 million under this plan primarily related to the impairment of property, plant and equipment at the Thailand facility.

In addition, in conjunction with the closure of its Thailand Facility, the Company recorded a write-down of inventory of $1.1 million in the first quarter of 2022 within cost of sales in the consolidated condensed statements of operations.

See Note 15 entitled “Restructuring and Other Charges” of Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information.

Interest Expense

During the quarter ended April 3, 2022, interest expense was $6.9 million, a decrease of $0.4 million from the comparable period in 2021, primarily due to lower outstanding term loan borrowings under the Facility.

Segment Operating Results

AMS Segment - Net Sales and Adjusted Operating Income (“AOI”)

The following table presents AMS segment net sales and AOI for the three-month periods ended April 3, 2022, and April 4, 2021:

(in thousands)

Three Months Ended April 3, 2022 April 4, 2021 Percentage Change
AMS segment net sales $156,509 $126,967 23.3%
AMS segment AOI(1) 21,138 11,913 77.4%

(1) Includes allocation of corporate SG&A expenses. Excludes non-recurring items related to restructuring, asset impairment, severance and other costs. See Note 11 entitled “Segment Information” of Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information.

During the first quarter of 2022, net sales in AMS increased 23.3% versus the comparable period in 2021 primarily due to higher sales volume and prices in the corporate office, education and healthcare market segments.

AOI in AMS increased 77.4% during the first quarter of 2022 compared to the prior year period primarily due to higher sales. The increase in AOI was also due to higher pricing and favorable fixed cost absorption, partially offset by higher raw material costs, higher freight costs, and higher labor costs as a result of continuing inflationary pressures.

EAAA Segment - Net Sales and AOI

The following table presents EAAA segment net sales and AOI for the three-month periods ended April 3, 2022, and April 4, 2021:

(in thousands)

Three Months Ended April 3, 2022 April 4, 2021 Percentage Change
EAAA segment net sales $131,493 $126,293 4.1%
EAAA segment AOI(1) 9,504 8,011 18.6%

(1) Includes allocation of corporate SG&A expenses. Excludes non-recurring items related to purchase accounting amortization, Thailand plant closure inventory write-down, and restructuring, asset impairment, severance and other costs. See Note 11 entitled “Segment Information” of Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information.

During the first quarter of 2022, net sales in EAAA increased 4.1% versus the comparable period in 2021. Currency fluctuations had a negative impact on EAAA sales of approximately $7.9 million (6.3%) for the first quarter 2022 compared to the same period last year due to the weakening of the Euro, British Pound sterling, and Australian dollar against the U.S. dollar. During the first quarter of 2022, EAAA sales were adversely impacted by new government imposed COVID-19 lockdowns in parts of China. On a market segment basis, the EAAA sales increase was most significant in the corporate office and healthcare market segments, partially offset by decreases in the public buildings market segment.

AOI in EAAA increased 18.6% during the first quarter of 2022 versus the comparable period in 2021 primarily due to the impact of higher sales. Currency fluctuations had a negative impact on AOI of approximately $1.0 million (6.8%) for the first quarter of 2022 compared to the first quarter last year. EAAA SG&A expenses as a percentage of net sales in the first quarter of 2022 decreased approximately 3% compared to the first quarter of 2021, which contributed to the increase in AOI for the first quarter of 2022. AOI in the first quarter of 2022 was adversely impacted by higher raw material costs, higher freight costs, and higher labor costs as a result of continuing inflationary pressures.

Liquidity and Capital Resources

General

At April 3, 2022, the Company had $76.1 million in cash. At that date, the Company had $213.5 million in term loan borrowings, $15.0 million in revolving loan borrowings, and $1.6 million in letters of credit outstanding under our Facility, and we had $300.0 million of Senior Notes outstanding. As of April 3, 2022, we had additional borrowing capacity of $283.4 million under the Facility and $4.0 million of borrowing capacity under other credit facilities in place at other non-U.S. subsidiaries. We anticipate that our liquidity is sufficient to meet our obligations for the next 12 months.

The Senior Notes are unsecured and are guaranteed, jointly and severally, by each of the Company’s material domestic subsidiaries, all of which also guarantee the obligations of the Company under its existing Facility. The Company’s foreign subsidiaries and certain non-material domestic subsidiaries are considered non-guarantors. Net sales for the non-guarantor subsidiaries were approximately $144 million and $136 million for the three-month periods ended April 3, 2022 and April 4, 2021, respectively. Total indebtedness of the non-guarantor subsidiaries was approximately $43 million and $45 million as of April 3, 2022 and January 2, 2022, respectively.

Analysis of Cash Flows

The following table presents a summary of cash flows for the three-month periods ended April 3, 2022 and April 4, 2021, respectively:

(in thousands)

Net cash provided by (used in): Three Months Ended April 3, 2022 April 4, 2021
Operating activities $(17,696) $24,855
Investing activities (4,781) (5,214)
Financing activities 2,894 (12,981)
Effect of exchange rate changes on cash (1,581) (2,790)
Net change in cash and cash equivalents (21,164) 3,870
Cash and cash equivalents at beginning of period 97,252 103,053
Cash and cash equivalents at end of period $76,088 $106,923

Cash used in operating activities was $17.7 million for the three months ended April 3, 2022, which represents a decrease of $42.6 million compared with cash provided by operating activities in the prior year comparable period. The decrease was primarily due to a greater use of cash for working capital during the first three months of 2022. Specifically, higher inventories as a result of increased customer demand, raw material costs and input costs contributed to the greater use of cash for working capital compared to last year. Accrued bonus payments during the first quarter of 2022 also contributed to the increased use of cash. These uses of cash were partially offset by higher accounts receivable collections during the first quarter of 2022.

Cash used in investing activities was $4.8 million for the three months ended April 3, 2022, which represents a decrease of $0.4 million from the prior year comparable period. The decrease from the comparable period was primarily due to a decrease in capital expenditures due to reduced capital investment.

Cash provided by financing activities was $2.9 million for the three months ended April 3, 2022, which represents an increase of $15.9 million compared with cash used in financing activities in the prior year comparable period. The year-over-year increase was primarily due to higher revolving loan borrowings in 2022 to fund operating activities as described above.

Purchase Obligations

In March of 2022, we entered into a purchase obligations commitment to procure fiberglass raw materials through the end of 2026 for approximately $22.5 million. We expect that approximately $4.5 million will be purchased within the next 12 months.

Forward-Looking Statement on Impact of COVID-19

While we are aggressively managing our response to the COVID-19 pandemic, its impacts on our full fiscal year 2022 results and beyond are uncertain. We believe the most significant elements of uncertainty are (1) the intensity and duration of the impact on construction, renovation, and remodeling; (2) corporate, government, and consumer spending levels and sentiment; (3) the ability of our sales channels, supply chain, manufacturing, and distribution partners to continue operating through disruptions; and (4) the severity of global supply chain disruptions and their effects on inflation, labor shortages, raw material shortages, and other factors that disrupt our supply chain and manufacturing facilities. Any or all of these factors could negatively impact our financial position, results of operations, cash flows, and outlook. As the impact of the COVID-19 pandemic continues to affect companies with global operations, specifically as it relates to the global supply chain, we anticipate that, at a minimum, our business and results in the first half of 2022 will continue to be affected, and the timeline and pace of recovery is uncertain.

We anticipate revenue growth in the second quarter of fiscal year 2022 compared with the first quarter of 2022. We are also anticipating continued impacts to our global supply chain and manufacturing operations. These impacts are expected to include significant cost increases in our raw materials globally and continued labor shortages and cost increases. The impacts may also potentially include raw material shortages, higher freight costs, shipping delays, and other disruption. These impacts to our supply chain and manufacturing will increase our costs and adversely affect our gross margins, they may inhibit our ability to manufacture and ship product timely, and at times they may inhibit our ability to meet customer demands and expectations.

We also plan to continue evaluating our cost structure and global manufacturing footprint to identify and activate opportunities to decrease costs and optimize our global cost structure.

Cash flows from operations, cash and cash equivalents, and other sources of liquidity are expected to be available and sufficient to meet foreseeable cash requirements. However, the Company’s cash flows from operations can be affected by numerous factors including the uncertainty of COVID-19 and its impact on global operations, raw material availability and cost, and demand for our products.

Backlog

As of April 24, 2022, the consolidated backlog of orders was approximately $266.6 million. As disclosed in our Annual Report on Form 10-K for the fiscal year ended January 2, 2022, backlog was approximately $215.6 million as of February 6, 2022. Disruptions in supply and distribution chains, global travel restrictions and government imposed lockdowns due to the impact of COVID-19 have resulted in delays of construction projects and flooring installations in many regions worldwide.

Market risk

As filed, 2,592 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The discussion below in this Item 3 is based upon the more detailed discussions of our market risk and related matters included in our Annual Report on Form 10-K for the fiscal year ended January 2, 2022, under Part II, Item 7A of that Form 10-K. The discussion here focuses on the three months ended April 3, 2022, and any material changes from (or other important intervening developments since the time of) the information discussed in that Form 10-K. This discussion should be read in conjunction with that Form 10-K for more detailed and background information.

Sensitivity Analysis

For purposes of specific risk analysis, we use sensitivity analysis to measure the impact that market risk may have on the fair values of our market sensitive instruments. To perform sensitivity analysis, we assess the risk of loss in fair values associated with the impact of hypothetical changes in interest rates and foreign currency exchange rates on market sensitive instruments.

Because the debt outstanding under our Facility has variable interest rates based on an underlying prime lending rate or LIBOR rate (or alternative successor benchmark rate), we do not believe changes in interest rates would have any significant impact on the fair value of that debt instrument. Changes in the underlying prime lending rate or LIBOR rate (or alternative successor benchmark rate) would, however, impact the amount of our interest expense. For a discussion of these hypothetical impacts on our interest expense, please see the discussion in Part II, Item 7A of our Annual Report on Form 10-K for the year ended January 2, 2022.

As of April 3, 2022, based on a hypothetical immediate 100 basis point increase in interest rates, with all other variables held constant, the fair value of our fixed rate long-term debt would be impacted by a net decrease of $15.3 million. Conversely, a 100 basis point decrease in interest rates would result in a net increase in the fair value of our fixed rate long-term debt of $14.0 million.

As of April 3, 2022, a 10% decrease or increase in the levels of foreign currency exchange rates against the U.S. dollar, with all other variables held constant, would result in a decrease in the fair value of our financial instruments of $8.6 million or an increase in the fair value of our financial instruments of $10.5 million, respectively. As the impact of offsetting changes in the fair market value of our net foreign investments is not included in the sensitivity model, these results are not indicative of our actual exposure to foreign currency exchange risk.

Controls and procedures

As filed, 1,521 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation was performed under the supervision and with the participation of our management, including our President and Chief Executive Officer and our Vice President and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Act”), pursuant to Rule 13a-14(c) under the Act.

No system of controls, no matter how well designed and operated, can provide absolute assurance that the objectives of the system of controls are met, and no evaluation of controls can provide absolute assurance that the system of controls has operated effectively in all cases. Our disclosure controls and procedures however are designed to provide reasonable assurance that the objectives of disclosure controls and procedures are met.

Based on the evaluation, our President and Chief Executive Officer and our Vice President and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report to provide reasonable assurance that the objectives of disclosure controls and procedures are met.

There were no changes in our internal control over financial reporting that occurred during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 3,397 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In addition to the other information set forth in this report, you should carefully consider the risk factors disclosed in Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the year ended January 2, 2022, as well as the following new risk factor which updates the risk factors set forth in our Annual Report:

The conflict between Russia and Ukraine could adversely affect our business, results of operations and financial position.

Given the nature of our business and our global operations, political, economic, and other conditions in foreign countries and regions, including geopolitical risks arising from the conflict between Russia and Ukraine, may adversely affect our business, results of operations and financial position. While our business activities within the countries of Russia and Ukraine are not material, the broader consequences of this conflict and the extent of its effects on us as well as the global economy cannot be predicted. These consequences include or may include government sanctions, embargoes, regional instability, geopolitical shifts, potential retaliatory action by the Russian government against companies or other countries, and increased tensions between Russia and the United States or other countries in which we operate.

Russia is a key supplier of natural gas, oil, and other raw materials to European countries. We have substantial manufacturing operations in Europe (including Germany, the Netherlands, and the United Kingdom), and we have key suppliers in Europe, which rely upon natural gas, oil, and other raw materials to operate. Our sole rubber flooring plant is in Germany, and our primary European carpet tile plant is in the Netherlands. Any disruption in the supply of natural gas, oil, or other raw materials from Russia to Europe could adversely affect our ability to operate our business, our results of operations and our financial position, or adversely affect the ability of our key suppliers to meet our raw material requirements. Our customers’ businesses, results of operations and financial positions also could be adversely impacted by the conflict in Ukraine, which could reduce their spending on our products.

The conflict between Russia and Ukraine is ongoing and its duration is uncertain. We cannot predict the outcome of the conflict or its impact on the broader region, as the conflict and related government actions are evolving and are beyond our control. To the extent the conflict between Russia and Ukraine adversely affects our business, it may also have the effect of heightening other risks disclosed in our Annual Report, any of which could materially and adversely affect our business, results of operations and financial condition. Such risks include, but are not limited to, adverse effects on macroeconomic conditions, including inflation and corporate and consumer spending; disruptions to our global technology infrastructure, including through cyberattack, ransom attack, or cyber-intrusion; adverse changes in international trade policies and relations; our ability to maintain or increase our prices, including fuel surcharges in response to rising fuel costs; further disruptions in global supply chains; terrorist activities targeting business infrastructure; our exposure to foreign currency fluctuations; and constraints, volatility, or disruption in the capital markets.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-04-03. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-01-03 to 2022-04-03$288.0mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-01-03 to 2022-04-03$181.2mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2022-01-03 to 2022-04-03$106.8mus-gaap:GrossProfit
Selling, general and administrative3 months2022-01-03 to 2022-04-03$78.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-01-03 to 2022-04-03$27.4mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-01-03 to 2022-04-03$6.8mus-gaap:InterestExpense
Income tax3 months2022-01-03 to 2022-04-03$7.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-01-03 to 2022-04-03$13.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-01-03 to 2022-04-03$0.22us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-01-03 to 2022-04-03$0.22us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-01-03 to 2022-04-0359,248,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2022-01-03 to 2022-04-03−$17.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-01-03 to 2022-04-03$4.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-04-03$76.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-04-03$583.8mus-gaap:AssetsCurrent
Total assetsAt period end2022-04-03$1.31bnus-gaap:Assets
Current liabilitiesAt period end2022-04-03$245.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-04-03$942.9mus-gaap:Liabilities
Long-term debtAt period end2022-04-03$506.8mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2022-04-03$14.9mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2022-04-03$366.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000715787-22-000019. Last ingested by Listed: Nov 12, 2026, 19:48 ET. Listed shows no prices and gives no investment advice.